IP Library Granted Patent US 9,120,759
Granted Patent B2
US 9,120,759 · App. 14/373,439 · Granted Sep 1, 2015

Process for the stereoselective preparation of a pyrazole carboxamide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,120,759
App. No.
14/373,439
Granted
Sep 1, 2015
Kind
B2
Abstract

The present invention relates to a process for the enantioselective preparation of 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ((1S,4R)-9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide of formula Ib.

Claims (27)

1. A process for the enantioselective preparation of 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid ((1S,4R)-9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide of formula lb

which process comprises

a) reducing a compound of formula II

with an enantioselective reagent to a compound of formula IIIe

b) dehydrating the compound of formula IIIe in the presence of an acid to the compound of formula IVa

c) reacting the compound of formula IVa with hydroxylamine to the compound of formula Va

and

d) acylating the oxime oxygen of the compound of formula Va in the presence of a solvent and an acylating agent and finally reacting the obtained product with the compound of formula VI

 or

e) reacting the compound of formula V with an excess of the compound of formula VI.

2. A process according to claim 1 , wherein the enantioselective reduction of the compound of formula II is done via hydrogenation in the presence of a transition metal catalyst.

3. A process according to claim 1 , wherein the enantioselective reduction of the compound of formula II is done via transfer hydrogenation in the presence of a transition metal catalyst.

4. A process according to claim 1 , wherein the enantioselective reagent is a ruthenium catalyst.

5. A process according to claim 2 , wherein the enantioselective reagent is a ruthenium catalyst.

6. A process according to claim 3 , wherein the enantioselective reagent is a ruthenium catalyst.

7. A process according to claim 1 , wherein the enantioselective reagent is chloro{(R)-(+)-2,2′-bis[di(3,5-xylyl)phosphino]-1,1′-binaphthyl}[(2R)-(+)1-(4-methoxyphenyl) -1′-(4-methoxyphenyl-kC)-3-methyl-1,2-butanediamine]ruthenium(II).

8. A process according to claim 1 , wherein the enantioselective reagent is dichloro[(4S,5S)-(+)-4,5-bis(diphenylphosphinomethyl)-2,2-dimethyl-1,3-dioxolane ][(S)-(−)-2-(α-methylmethanamine)-1 H-benzimidazole]ruthenium(II).

9. The compound (1S,4R)-9-dichloromethylene-8-hydroxy -octahydro-1,4-methano-naphthalen-5-one of formula IIle

or a spatial isomer thereof.

10. The compound (1S,4R)-9-dichloromethylene-2,3,4,6,7,8-hexahydro-1 H-1 ,4-methano-naphthalen-5-one of formula

or a spatial isomer thereof.

11. The compound (1 S,4R)-9-dichloromethylene-2,3,4,6,7,8-hexahydro-1H-1,4-methano-naphthalen-5-one oxime of formula Va

or a spatial isomer thereof.

12. A compound of formula XXIIIa

wherein X is oxygen or sulfur, R 1 is C 1 -C 6 alkoxy, CH 3 —C(═CH 2 )—O —, phenoxy or trichloromethoxy; or a spatial isomer thereof.

13. A compound of formula XXIVa

wherein X is oxygen or sulfur, or a spatial isomer thereof.

Assignments (2)
MERGER AND CHANGE OF NAME Recorded Mar 14, 2025
From: SYNGENTA PARTICIPATIONS AG; SYNGENTA PARTICIPATIONS AG
To: SYNGENTA CROP PROTECTION AG
Reel/Frame 070517/0493 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2015
From: SMEJKAL, TOMAS
To: SYNGENTA PARTICIPATIONS AG
Reel/Frame 035588/0058 →